{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T14:19:05Z","timestamp":1754144345671,"version":"3.41.2"},"posted":{"date-parts":[[2025,7,15]]},"group-title":"In Review","reference-count":50,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,6,20]]},"abstract":"<title>Abstract<\/title>\n        <p>Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that leads to the loss of motor neurons, resulting in paralysis and death. Currently, there are no specific biomarkers available for diagnosing ALS. As a result, diagnosis currently relies on excluding other conditions, which forces patients to endure months or even years of uncertainty. The absence of a specific, reliable diagnostic tool has hindered both early intervention and therapeutic progress. Here we develop a novel synthetic antibody that can detect a toxic form of a known protein linked to ALS. This trimeric assembly of superoxide dismutase 1 (SOD1) is a soluble, structurally distinct oligomer that is highly toxic in cell models. The antibody selectively binds this trimer and differentiates individuals with the disease from healthy people and from those with other neurodegenerative diseases (Alzheimer\u2019s and Parkinson\u2019s disease). This breakthrough provides the first disease-specific diagnostic tool for this condition and reveals a shared pathological signature across patients, even in cases without genetic mutations. After decades without a specific diagnostic tool, this antibody signifies a long-awaited breakthrough, finally offering clinicians and researchers a reliable window into ALS pathology.<\/p>","DOI":"10.21203\/rs.3.rs-6941118\/v1","type":"posted-content","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T12:19:29Z","timestamp":1752581969000},"source":"Crossref","is-referenced-by-count":0,"title":["Trimeric superoxide dismutase 1 antibody as a universal biomarker for ALS"],"prefix":"10.21203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8225-4025","authenticated-orcid":false,"given":"Nikolay","family":"Dokholyan","sequence":"first","affiliation":[{"name":"Penn State College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brianna","family":"Hnath","sequence":"additional","affiliation":[{"name":"Penn State College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6785-7693","authenticated-orcid":false,"given":"Rachel","family":"Dokholyan","sequence":"additional","affiliation":[{"name":"Penn State Health"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zachary","family":"Simmons","sequence":"additional","affiliation":[{"name":"Penn State Health"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","first-page":"215","volume-title":"Progress in Molecular Biology and Translational Science","author":"Redler RL","year":"2012","unstructured":"Redler RL, Dokholyan NV (2012) The Complex Molecular Biology of Amyotrophic Lateral Sclerosis (ALS). Progress in Molecular Biology and Translational Science, vol 107. Elsevier, pp 215\u2013262"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.sbi.2020.12.002","article-title":"SOD1 oligomers in amyotrophic lateral sclerosis","volume":"66","author":"Choi ES","year":"2021","unstructured":"Choi ES, Dokholyan NV (2021) SOD1 oligomers in amyotrophic lateral sclerosis. Curr Opin Struct Biol 66:225\u2013230","journal-title":"Curr Opin Struct Biol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.1007\/s00415-024-12462-6","article-title":"The various forms of hereditary motor neuron disorders and their historical descriptions","volume":"271","author":"Mathis S","year":"2024","unstructured":"Mathis S, Beauvais D, Duval F, Sol\u00e9 G, Le Masson G (2024) The various forms of hereditary motor neuron disorders and their historical descriptions. J Neurol 271:3978\u20133990","journal-title":"J Neurol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nrneurol.2014.184","article-title":"The phenotypic variability of amyotrophic lateral sclerosis","volume":"10","author":"Swinnen B","year":"2014","unstructured":"Swinnen B, Robberecht W (2014) The phenotypic variability of amyotrophic lateral sclerosis. Nat Rev Neurol 10:661\u2013670","journal-title":"Nat Rev Neurol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S1474-4422(13)70036-X","article-title":"Controversies and priorities in amyotrophic lateral sclerosis","volume":"12","author":"Turner MR","year":"2013","unstructured":"Turner MR et al (2013) Controversies and priorities in amyotrophic lateral sclerosis. Lancet Neurol 12:310\u2013322","journal-title":"Lancet Neurol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13024-022-00515-1","article-title":"Blood-based biomarkers of inflammation in amyotrophic lateral sclerosis","volume":"17","author":"Staats KA","year":"2022","unstructured":"Staats KA, Borchelt DR, Tansey MG, Wymer J (2022) Blood-based biomarkers of inflammation in amyotrophic lateral sclerosis. Mol Neurodegener 17:11","journal-title":"Mol Neurodegener"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1093\/brain\/awac077","article-title":"Biomarker discovery and development for frontotemporal dementia and amyotrophic lateral sclerosis","volume":"145","author":"Katzeff JS","year":"2022","unstructured":"Katzeff JS et al (2022) Biomarker discovery and development for frontotemporal dementia and amyotrophic lateral sclerosis. Brain 145:1598\u20131609","journal-title":"Brain"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/j.clinph.2020.04.005","article-title":"A proposal for new diagnostic criteria for ALS","volume":"131","author":"Shefner JM","year":"2020","unstructured":"Shefner JM et al (2020) A proposal for new diagnostic criteria for ALS. Clin Neurophysiol 131:1975\u20131978","journal-title":"Clin Neurophysiol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.clinph.2007.09.143","article-title":"Electrodiagnostic criteria for diagnosis of ALS","volume":"119","author":"Carvalho M","year":"2008","unstructured":"De Carvalho M et al (2008) Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol 119:497\u2013503","journal-title":"Clin Neurophysiol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/0022-510X(94)90191-0","article-title":"El escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis","volume":"124","author":"Brooks BR","year":"1994","unstructured":"Brooks BR (1994) El escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. J Neurol Sci 124:96\u2013107","journal-title":"J Neurol Sci"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S1474-4422(21)00465-8","article-title":"Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis","volume":"21","author":"Goutman SA","year":"2022","unstructured":"Goutman SA et al (2022) Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis. Lancet Neurol 21:480\u2013493","journal-title":"Lancet Neurol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1021\/acs.chemrev.0c01122","article-title":"Amyloid Oligomers: A Joint Experimental\/Computational Perspective on Alzheimer\u2019s Disease, Parkinson\u2019s Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis","volume":"121","author":"Nguyen PH","year":"2021","unstructured":"Nguyen PH et al (2021) Amyloid Oligomers: A Joint Experimental\/Computational Perspective on Alzheimer\u2019s Disease, Parkinson\u2019s Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis. Chem Rev 121:2545\u20132647","journal-title":"Chem Rev"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/362059a0","article-title":"Mutations in Cu\/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis","volume":"362","author":"Rosen DR","year":"1993","unstructured":"Rosen DR et al (1993) Mutations in Cu\/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362:59\u201362","journal-title":"Nature"},{"year":"2004","author":"Khare SD","unstructured":"Khare SD, Caplow M, Dokholyan NV (2004) The rate and equilibrium constants for a multistep reaction sequence for the aggregation of superoxide dismutase in amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. 101, 15094\u201315099","key":"ref14"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1126\/science.8209258","article-title":"Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation","volume":"264","author":"Gurney ME","year":"1994","unstructured":"Gurney ME et al (1994) Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation. Science 264:1772\u20131775","journal-title":"Science"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/ng0596-43","article-title":"Motor neurons in Cu\/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury","volume":"13","author":"Reaume AG","year":"1996","unstructured":"Reaume AG et al (1996) Motor neurons in Cu\/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nat Genet 13:43\u201347","journal-title":"Nat Genet"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13024-015-0053-4","article-title":"SOD1 protein aggregates stimulate macropinocytosis in neurons to facilitate their propagation","volume":"10","author":"Zeineddine R","year":"2015","unstructured":"Zeineddine R et al (2015) SOD1 protein aggregates stimulate macropinocytosis in neurons to facilitate their propagation. Mol Neurodegener 10:57","journal-title":"Mol Neurodegener"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1007\/s12035-018-1218-2","article-title":"Pathological Modification of TDP-43 in Amyotrophic Lateral Sclerosis with SOD1 Mutations","volume":"56","author":"Jeon GS","year":"2019","unstructured":"Jeon GS et al (2019) Pathological Modification of TDP-43 in Amyotrophic Lateral Sclerosis with SOD1 Mutations. Mol Neurobiol 56:2007\u20132021","journal-title":"Mol Neurobiol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"14223","DOI":"10.1038\/s41598-018-31773-z","article-title":"Misfolded SOD1 pathology in sporadic Amyotrophic Lateral Sclerosis","volume":"8","author":"Par\u00e9 B","year":"2018","unstructured":"Par\u00e9 B et al (2018) Misfolded SOD1 pathology in sporadic Amyotrophic Lateral Sclerosis. Sci Rep 8:14223","journal-title":"Sci Rep"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"e11552","DOI":"10.1371\/journal.pone.0011552","article-title":"Novel Antibodies Reveal Inclusions Containing Non-Native SOD1 in Sporadic ALS Patients","volume":"5","author":"Forsberg K","year":"2010","unstructured":"Forsberg K et al (2010) Novel Antibodies Reveal Inclusions Containing Non-Native SOD1 in Sporadic ALS Patients. PLoS ONE 5:e11552","journal-title":"PLoS ONE"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"7057","DOI":"10.1021\/bi200614y","article-title":"Glutathionylation at Cys-111 Induces Dissociation of Wild Type and FALS Mutant SOD1 Dimers","volume":"50","author":"Redler RL","year":"2011","unstructured":"Redler RL et al (2011) Glutathionylation at Cys-111 Induces Dissociation of Wild Type and FALS Mutant SOD1 Dimers. Biochemistry 50:7057\u20137066","journal-title":"Biochemistry"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"101270","DOI":"10.1016\/j.redox.2019.101270","article-title":"Mechanisms of SOD1 regulation by post-translational modifications","volume":"26","author":"Banks CJ","year":"2019","unstructured":"Banks CJ, Andersen JL (2019) Mechanisms of SOD1 regulation by post-translational modifications. Redox Biol 26:101270","journal-title":"Redox Biol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"13940","DOI":"10.1074\/jbc.M809687200","article-title":"Modifications of Superoxide Dismutase (SOD1) in Human Erythrocytes","volume":"284","author":"Wilcox KC","year":"2009","unstructured":"Wilcox KC et al (2009) Modifications of Superoxide Dismutase (SOD1) in Human Erythrocytes. J Biol Chem 284:13940\u201313947","journal-title":"J Biol Chem"},{"year":"2006","author":"Khare SD","unstructured":"Khare SD, Dokholyan NV (2006) Common dynamical signatures of familial amyotrophic lateral sclerosis-associated structurally diverse Cu, Zn superoxide dismutase mutants. Proc. Natl. Acad. Sci. 103, 3147\u20133152","key":"ref24"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41419-017-0106-4","article-title":"Pathological hydrogen peroxide triggers the fibrillization of wild-type SOD1 via sulfenic acid modification of Cys-111","volume":"9","author":"Xu W-C","year":"2018","unstructured":"Xu W-C et al (2018) Pathological hydrogen peroxide triggers the fibrillization of wild-type SOD1 via sulfenic acid modification of Cys-111. Cell Death Dis 9:67","journal-title":"Cell Death Dis"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3109\/17482960802455416","article-title":"Exposure to chemicals and metals and risk of amyotrophic lateral sclerosis: A systematic review","volume":"10","author":"Sutedja NA","year":"2009","unstructured":"Sutedja NA et al (2009) Exposure to chemicals and metals and risk of amyotrophic lateral sclerosis: A systematic review. Amyotroph Lateral Scler 10:302\u2013309","journal-title":"Amyotroph Lateral Scler"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"e1007225","DOI":"10.1371\/journal.pcbi.1007225","article-title":"\u03b2-Methylamino-L-alanine substitution of serine in SOD1 suggests a direct role in ALS etiology","volume":"15","author":"Proctor EA","year":"2019","unstructured":"Proctor EA, Mowrey DD, Dokholyan NV (2019) \u03b2-Methylamino-L-alanine substitution of serine in SOD1 suggests a direct role in ALS etiology. PLOS Comput Biol 15:e1007225","journal-title":"PLOS Comput Biol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1021\/acschembio.8b00729","article-title":"Investigation of Anti-SOD1 Antibodies Yields New Structural Insight into SOD1 Misfolding and Surprising Behavior of the Antibodies Themselves","volume":"13","author":"Atlasi RS","year":"2018","unstructured":"Atlasi RS et al (2018) Investigation of Anti-SOD1 Antibodies Yields New Structural Insight into SOD1 Misfolding and Surprising Behavior of the Antibodies Themselves. ACS Chem Biol 13:2794\u20132807","journal-title":"ACS Chem Biol"},{"key":"ref29","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2013.00253","article-title":"An emerging role for misfolded wild-type SOD1 in sporadic ALS pathogenesis","volume":"7","author":"Rotunno MS","year":"2013","unstructured":"Rotunno MS, Bosco DA (2013) An emerging role for misfolded wild-type SOD1 in sporadic ALS pathogenesis. Front Cell Neurosci 7","journal-title":"Front Cell Neurosci"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"22155","DOI":"10.1038\/srep22155","article-title":"TDP-43 or FUS-induced misfolded human wild-type SOD1 can propagate intercellularly in a prion-like fashion","volume":"6","author":"Pokrishevsky E","year":"2016","unstructured":"Pokrishevsky E, Grad LI, Cashman NR (2016) TDP-43 or FUS-induced misfolded human wild-type SOD1 can propagate intercellularly in a prion-like fashion. Sci Rep 6:22155","journal-title":"Sci Rep"},{"year":"2011","author":"Grad LI","unstructured":"Grad LI et al (2011) Intermolecular transmission of superoxide dismutase 1 misfolding in living cells. Proc. Natl. Acad. Sci. 108, 16398\u201316403","key":"ref31"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00401-017-1688-8","article-title":"Misfolded SOD1 is not a primary component of sporadic ALS","volume":"134","author":"Cruz S","year":"2017","unstructured":"Da Cruz S et al (2017) Misfolded SOD1 is not a primary component of sporadic ALS. Acta Neuropathol (Berl) 134:97\u2013111","journal-title":"Acta Neuropathol (Berl)"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/ana.21704","article-title":"Lack of evidence of monomer\/misfolded superoxide dismutase-1 in sporadic amyotrophic lateral sclerosis","volume":"66","author":"Liu H-N","year":"2009","unstructured":"Liu H-N et al (2009) Lack of evidence of monomer\/misfolded superoxide dismutase-1 in sporadic amyotrophic lateral sclerosis. Ann Neurol 66:75\u201380","journal-title":"Ann Neurol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1021\/bi500158w","article-title":"Non-native Soluble Oligomers of Cu\/Zn Superoxide Dismutase (SOD1) Contain a Conformational Epitope Linked to Cytotoxicity in Amyotrophic Lateral Sclerosis (ALS)","volume":"53","author":"Redler RL","year":"2014","unstructured":"Redler RL, Fee L, Fay JM, Caplow M, Dokholyan NV (2014) Non-native Soluble Oligomers of Cu\/Zn Superoxide Dismutase (SOD1) Contain a Conformational Epitope Linked to Cytotoxicity in Amyotrophic Lateral Sclerosis (ALS). Biochemistry 53:2423\u20132432","journal-title":"Biochemistry"},{"year":"2016","author":"Proctor EA","unstructured":"Proctor EA et al (2016) Nonnative SOD1 trimer is toxic to motor neurons in a model of amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. 113, 614\u2013619","key":"ref35"},{"year":"2018","author":"Zhu C","unstructured":"Zhu C, Beck MV, Griffith JD, Deshmukh M, Dokholyan NV (2018) Large SOD1 aggregates, unlike trimeric SOD1, do not impact cell viability in a model of amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. 115, 4661\u20134665","key":"ref36"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpj.2022.04.037","article-title":"Toxic SOD1 trimers are off-pathway in the formation of amyloid-like fibrils in ALS","volume":"S0006349522003654","author":"Hnath B","year":"2022","unstructured":"Hnath B, Dokholyan NV (2022) Toxic SOD1 trimers are off-pathway in the formation of amyloid-like fibrils in ALS. Biophys J S0006349522003654. 10.1016\/j.bpj.2022.04.037","journal-title":"Biophys J"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0022-510X(99)00210-5","article-title":"The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function","volume":"169","author":"Cedarbaum JM","year":"1999","unstructured":"Cedarbaum JM et al (1999) The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. J Neurol Sci 169:13\u201321","journal-title":"J Neurol Sci"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3389\/fneur.2019.00400","article-title":"A Systematic Review of Suggested Molecular Strata, Biomarkers and Their Tissue Sources in ALS","volume":"10","author":"Vijayakumar UG","year":"2019","unstructured":"Vijayakumar UG et al (2019) A Systematic Review of Suggested Molecular Strata, Biomarkers and Their Tissue Sources in ALS. Front Neurol 10:400","journal-title":"Front Neurol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1001\/jamaneurol.2022.3282","article-title":"Amyotrophic Lateral Sclerosis Clinical Trials and Interpretation of Functional End Points and Fluid Biomarkers: A Review","volume":"79","author":"Shefner JM","year":"2022","unstructured":"Shefner JM et al (2022) Amyotrophic Lateral Sclerosis Clinical Trials and Interpretation of Functional End Points and Fluid Biomarkers: A Review. JAMA Neurol 79:1312","journal-title":"JAMA Neurol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s13311-016-0503-x","article-title":"Fluid-Based Biomarkers for Amyotrophic Lateral Sclerosis","volume":"14","author":"Vu LT","year":"2017","unstructured":"Vu LT, Bowser R (2017) Fluid-Based Biomarkers for Amyotrophic Lateral Sclerosis. Neurotherapeutics 14:119\u2013134","journal-title":"Neurotherapeutics"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"496","DOI":"10.3390\/genes15040496","article-title":"Neurofilaments in Sporadic and Familial Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis","volume":"15","author":"Shahim P","year":"2024","unstructured":"Shahim P et al (2024) Neurofilaments in Sporadic and Familial Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis. Genes 15:496","journal-title":"Genes"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3109\/17482968.2011.585163","article-title":"Anti-superoxide dismutase antibodies are associated with survival in patients with sporadic amyotrophic lateral sclerosis","volume":"12","author":"Blitterswijk M","year":"2011","unstructured":"van Blitterswijk M et al (2011) Anti-superoxide dismutase antibodies are associated with survival in patients with sporadic amyotrophic lateral sclerosis. Amyotroph Lateral Scler 12:430\u2013438","journal-title":"Amyotroph Lateral Scler"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.neulet.2007.09.024","article-title":"Evidence for secretion of Cu,Zn superoxide dismutase via exosomes from a cell model of amyotrophic lateral sclerosis","volume":"428","author":"Gomes C","year":"2007","unstructured":"Gomes C, Keller S, Altevogt P, Costa J (2007) Evidence for secretion of Cu,Zn superoxide dismutase via exosomes from a cell model of amyotrophic lateral sclerosis. Neurosci Lett 428:43\u201346","journal-title":"Neurosci Lett"},{"year":"2014","author":"Grad LI","unstructured":"Grad LI et al (2014) Intercellular propagated misfolding of wild-type Cu\/Zn superoxide dismutase occurs via exosome-dependent and -independent mechanisms. Proc. Natl. Acad. Sci. 111, 3620\u20133625","key":"ref45"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nn1603","article-title":"Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis","volume":"9","author":"Urushitani M","year":"2006","unstructured":"Urushitani M et al (2006) Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis. Nat Neurosci 9:108\u2013118","journal-title":"Nat Neurosci"},{"year":"2025","author":"Hnath B","unstructured":"Hnath B, Dokholyan NV (2025) Novel extracellular vesicle release pathway facilitated by toxic superoxide dismutase 1 oligomers. BioRxiv","key":"ref47"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1074\/jbc.RA118.004825","article-title":"CNS-derived extracellular vesicles from superoxide dismutase 1 (SOD1)G93A ALS mice originate from astrocytes and neurons and carry misfolded SOD1","volume":"294","author":"Silverman JM","year":"2019","unstructured":"Silverman JM et al (2019) CNS-derived extracellular vesicles from superoxide dismutase 1 (SOD1)G93A ALS mice originate from astrocytes and neurons and carry misfolded SOD1. J Biol Chem 294:3744\u20133759","journal-title":"J Biol Chem"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1385\/1592598730","volume-title":"Immunochemical Protocols: Third Edition","author":"Burns R","year":"2005","unstructured":"Burns R (2005) Immunochemical Protocols: Third Edition. Humana, Totowa, NJ. 10.1385\/1592598730"},{"key":"ref50","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.596006","article-title":"Destination Amyotrophic Lateral Sclerosis","volume":"12","author":"Keon M","year":"2021","unstructured":"Keon M et al (2021) Destination Amyotrophic Lateral Sclerosis. Front Neurol 12","journal-title":"Front Neurol"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-6941118\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-6941118\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T12:19:34Z","timestamp":1752581974000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-6941118\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,15]]},"references-count":50,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-6941118\/v1","relation":{},"subject":[],"published":{"date-parts":[[2025,7,15]]},"subtype":"preprint"}}